Literature DB >> 12186918

Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.

Pascal Lopez1, Robert J Jacob, Bernard Roizman.   

Abstract

A key early event in the replication of herpes simplex virus 1 (HSV-1) is the localization of infected-cell protein no. 0 (ICP0) in nuclear structures knows as ND10 or promyelocytic leukemia oncogenic domains (PODs). This is followed by dispersal of ND10 constituents such as the promyelocytic leukemia protein (PML), CREB-binding protein (CBP), and Daxx. Numerous experiments have shown that this dispersal is mediated by ICP0. PML is thought to be the organizing structural component of ND10. To determine whether the virus targets PML because it is inimical to viral replication, telomerase-immortalized human foreskin fibroblasts and HEp-2 cells were transduced with wild-type baculovirus or a baculovirus expressing the M(r) 69,000 form of PML. The transduced cultures were examined for expression and localization of PML in mock-infected and HSV-1-infected cells. The results obtained from studies of cells overexpressing PML were as follows. (i) Transduced cells accumulate large amounts of unmodified and SUMO-I-modified PML. (ii) Mock-infected cells exhibited enlarged ND10 structures containing CBP and Daxx in addition to PML. (iii) In infected cells, ICP0 colocalized with PML in ND10 early in infection, but the two proteins did not overlap or were juxtaposed in orderly structures. (iv) The enlarged ND10 structures remained intact at least until 12 h after infection and retained CBP and Daxx in addition to PML. (v) Overexpression of PML had no effect on the accumulation of viral proteins representative of alpha, beta, or gamma groups and had no effect on the accumulation of infectious virus in cells infected with wild-type virus or a mutant (R7910) from which the alpha 0 genes had been deleted. These results indicate the following: (i) PML overexpressed in transduced cells cannot be differentiated from endogenous PML with respect to sumoylation and localization in ND10 structures. (ii) PML does not affect viral replication or the changes in the localization of ICP0 through infection. (iii) Disaggregation of ND10 structures is not an obligatory event essential for viral replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186918      PMCID: PMC136451          DOI: 10.1128/jvi.76.18.9355-9367.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Requirements for the nuclear-cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1.

Authors:  P Lopez; C Van Sant; B Roizman
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.

Authors:  C Van Sant; R Hagglund; P Lopez; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT.

Authors:  S Ganiatsas; R Dow; A Thompson; B Schulman; D Germain
Journal:  Oncogene       Date:  2001-06-21       Impact factor: 9.867

4.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs).

Authors:  S Torii; D A Egan; R A Evans; J C Reed
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

Review 6.  Role and fate of PML nuclear bodies in response to interferon and viral infections.

Authors:  T Regad; M K Chelbi-Alix
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

7.  Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML.

Authors:  J H Ahn; E J Brignole; G S Hayward
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.

Authors:  S Vallian; J A Gäken; E B Gingold; T Kouzarides; K S Chang; F Farzaneh
Journal:  Oncogene       Date:  1998-06-04       Impact factor: 9.867

9.  Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation.

Authors:  K Mattsson; K Pokrovskaja; C Kiss; G Klein; L Szekely
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

10.  Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Authors:  V Lallemand-Breitenbach; J Zhu; F Puvion; M Koken; N Honoré; A Doubeikovsky; E Duprez; P P Pandolfi; E Puvion; P Freemont; H de Thé
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  43 in total

Review 1.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells.

Authors:  Haidong Gu; Yu Liang; Gail Mandel; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

3.  ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression.

Authors:  Alice P W Poon; Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

4.  Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.

Authors:  Gregory J Block; Christopher H Eskiw; Graham Dellaire; David P Bazett-Jones
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

5.  Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitro.

Authors:  Sebla B Kutluay; Sarah L DeVos; Jennifer E Klomp; Steven J Triezenberg
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.

Authors:  Haidong Gu; Bernard Roizman
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

7.  Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1.

Authors:  Zhuan Li; Yohei Yamauchi; Maki Kamakura; Tsugiya Murayama; Fumi Goshima; Hiroshi Kimura; Yukihiro Nishiyama
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  During its nuclear phase the multifunctional regulatory protein ICP0 undergoes proteolytic cleavage characteristic of polyproteins.

Authors:  Haidong Gu; Alice P Poon; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-22       Impact factor: 11.205

Review 9.  The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex.

Authors:  Bernard Roizman
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

10.  Ret Finger Protein: An E3 Ubiquitin Ligase Juxtaposed to the XY Body in Meiosis.

Authors:  Isabelle Gillot; Cédric Matthews; Daniel Puel; Frédérique Vidal; Pascal Lopez
Journal:  Int J Cell Biol       Date:  2010-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.